|Day Low/High||15.35 / 16.13|
|52 Wk Low/High||11.00 / 23.53|
Upgrades: ALSN, MARPS Downgrades: BFS, BIG, FBNC, NSU, THOR Initiations: None Read on to get TheStreet Quant Ratings' detailed report:
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
TheStreet Ratings group highlights 4 stocks pushing the health services industry lower today.
In trading on Thursday, shares of Thoratec Corp. crossed below their 200 day moving average of $35.46, changing hands as low as $35.33 per share.
Unusual volume can also be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.
Sunshine's C-Pulse is a heart-assist device for patients who fall between the cracks of current therapy.
Thoratec's CEO Discusses Q2 2012 Results - Earnings Call Transcript
Thoratec's CEO Discusses Q1 2012 Results - Earnings Call Transcript
Here's a look at how some of the most-searched stocks are trading technically.
Shares of Thoratec Corporation (Nasdaq:THOR) were gapping up Thursday morning with an open price 15.3% higher than Wednesday's closing price. The stock closed at $30.81 yesterday and opened today's trading at $35.51.
Thoratec's CEO Discusses Q4 2011 Results - Earnings Call Transcript
Thoratec Corporation was a leading decliner within the health services industry, falling $1.02 (-3.4%) to $29.44 on heavy volume.
Thoratec shares are plunging in premarket trading Wednesday after the company gave a mixed full-year outlook.
Thoratec's CEO Discusses Q3 2011 Results - Earnings Call Transcript
JDS Uniphase shares surge in late trades after the company beats Wall Street expectations for its fiscal first quarter.
Thoratec Corporation (Nasdaq:THOR) hit a new 52-week high Monday as it is currently trading at $37.56, above its previous 52-week high of $37.55 with 353,100 shares traded as of 2:26 p.m. ET. Average volume has been 864,100 shares over the past 30 days.
Thoratec Corporation (Nasdaq:THOR) hit a new 52-week high Friday as it is currently trading at $37, above its previous 52-week high of $36.98 with 560,484 shares traded as of 1:50 p.m. ET. Average volume has been 847,900 shares over the past 30 days.
These stocks are setting up to break out and trade higher from current levels.
Thoratec's CEO Discusses Q2 2011 Results - Earnings Call Transcript
Shares of Thoratec Corporation (Nasdaq:THOR) were gapping up Monday morning with an open price 14.9% higher than Friday's closing price. The stock closed at $27.42 yesterday and opened today's trading at $31.51.
AT&T downgraded at UBS from Buy to Neutral. Jetblue downgraded at Soleil from Buy to Hold. Nokia upgraded at Morgan Keegan.
TheStreet presents its daily rundown of the winners and losers in the small-cap space
El Paso Electric is downgraded from Buy to Hold at Jefferies, which said the stock is already pricing in above-average earnings growth potential.
NEW YORK (TheStreet) -- Guests include Richard Soloway, CEO of Napco Security Technologies, Richard Ferri, author of "The Power of Passive Investing" and Gil Morales, managing director at MoKa Investors
These highly-rated large and mid-cap health care companies are growth plays with very strong sentiment among analysts.
To make money in stocks, follow broad growth trends, says Cabot Money Management's Dennis Wassung.
If a growth stock doesn't offer a dividend, you may have to take it yourself.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.